Japan's Terumo Integration With U.S.-based CardidianBCT Involved Cultural Customs
This article was originally published in PharmAsia News
Executive Summary
The purchase by Japan's Terumo last year of CaridianBCT, a U.S. maker of transfusion equipment and renamed Terumo BCT, is projected to see $12.8 billion in sales by 2020, according to President Yutaro Shintaku.